William Blair analyst Brian Drab has maintained their neutral stance on PRLB stock, giving a Hold rating today.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Brian Drab has given his Hold rating due to a combination of factors influencing Proto Labs. The company reported strong second-quarter results and provided positive guidance for the third quarter, which initially boosted the stock by 10%. The appointment of a new CEO, Suresh Krishna, who brings extensive experience and was a former customer, is seen as a positive development, potentially enhancing the company’s market strategy and reputation.
However, despite these positive developments, Drab remains cautious due to anticipated challenges in Proto Labs’ core injection molding business. Additionally, there is an expectation of a decline in earnings by 2025, which could limit the stock’s valuation growth in the near term. These factors collectively contribute to the Hold rating, reflecting a balanced view of potential opportunities and risks.

